Sort
261,768 grants matching “gene therapy”
Systems Biology of Airway Disease
$2,559,949Scott T Weiss · Brigham And Women'S Hospital · P01 · FY2017 · HL
Pulmonary Hypertension Breakthrough Initiative
$2,557,971Mark W Geraci · University Of Colorado Denver · R24 · FY2014 · HL
Novel Targets for GI Hormones and Neuropeptides in Regulation of Intestinal Motility
$2,557,146Sal Baker · University Of Nevada Reno · R01 · FY2025 · DK
Combination Therapies to Defeat Melanoma Resistance
$2,556,789Antoni Ribas · University Of California Los Angeles · P01 · FY2022 · CA
Combination Therapies to Defeat Melanoma Resistance
$2,556,789Antoni Ribas · University Of California Los Angeles · P01 · FY2023 · CA
Regulation of BRCA-dependent Genome Repair via the 53BP1 Axis
$2,556,071Patrick Sung · University Of Texas Hlth Science Center · P01 · FY2024 · CA
SPORE in Prostate Cancer
$2,555,905Mayo Clinic · P50 · FY2005 · CA
Lysosome Regulation and Signaling in Aging and Alzheimer's Disease
$2,555,846Hui Zheng · Baylor College Of Medicine · P01 · FY2025 · AG
Regulation of ER-stress Activated UPR kinase PERK in Neurodegenerative Diseases
$2,555,390James D Lechleiter · University Of Texas Hlth Science Center · RF1 · FY2019 · AG
Lentiviral Gene Therapy for Sickle Cell Disease and Immunodeficiency Disorders
$2,555,299Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2014 · HL
A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth
$2,555,013Rebecca Gersnoviez Clifton · George Washington University · U01 · FY2024 · HD
SPORE in Genitourinary Cancer
$2,554,804Colin P Dinney · University Of Tx Md Anderson Can Ctr · P50 · FY2006 · CA
Risk Factors for Onset and Persistence of TMD
$2,554,680William Maixner · Univ Of North Carolina Chapel Hill · U01 · FY2009 · DE
Elucidating Loci Involved in Prostate Cancer Suceptibility
$2,554,434Brian E Henderson · University Of Southern California · U19 · FY2012 · CA
Thymic and Peripheral Aspects of T Cell Aging and Rejuvenation
$2,554,238Janko Nikolich-Zugich · University Of Arizona · P01 · FY2025 · AG
Cell and Gene Therapy for Nonmalignant Blood Disorders
$2,554,007Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · P01 · FY2018 · HL
Risk Factors for Onset and Persistence of TMD
$2,552,556William Maixner · Univ Of North Carolina Chapel Hill · U01 · FY2010 · DE
Inherited Ocular Diseases
$2,550,614James F. Hejtmancik · National Eye Institute · Z01 · FY2008 · EY
RCMI Center for Interdiscplinary Health Research CIHR
$2,550,566George Perry · University Of Texas San Antonio · G12 · FY2014 · MD
Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE
$2,550,443Mark Thomas Gladwin · University Of Maryland Baltimore · UH3 · FY2024 · HL
SPORE in Genitourinary Cancer
$2,549,962Colin P Dinney · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA
Novel Cord Blood-Derived Cellular Therapies
$2,549,929Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
SPORE IN PROSTATE CANCER
$2,549,885Baylor College Of Medicine · P50 · FY2000 · CA
Psychotherapy Development Research Center
$2,549,855Kathleen M Carroll · Yale University · P50 · FY2016 · DA
DNA Sequencing and FACS Core Facilities
$2,549,754Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA